Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Proteus Biomedical
Asia
China bulk purchase, Takeda, Sinopharm and more—FiercePharmaAsia
Foreign pharmas lose in China's bulk procurement. Takeda is selling assets and reducing headcount in Japan. Sinopharm unveils COVID vax price limit.
Angus Liu
Aug 21, 2020 8:55am
Otsuka beats back Novartis opposition with $15M Proteus purchase
Aug 20, 2020 11:18am
Trend 2019: Digital therapeutics from pharma
Dec 19, 2018 9:40am
China's drug list, Rituxan biosim and more—FiercePharmaAsia
Oct 12, 2018 11:13am
Will new digital Abilify start a wave of smart pills?
Nov 14, 2017 11:36am
FDA device rebuff thwarts Abilify's adherence boost
Apr 28, 2016 11:44am
